A Phase I, Randomized, Placebo-controlled, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Activity of Repeated Intranasal Administration of Ampligen® (Poly I:Poly C12U) in Healthy Subjects

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2021
This article has no abstract
Epistemonikos ID: ca80312ac6834e274037ab1b0d057ff5010b54f8
First added on: Apr 11, 2025